BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 27252558)

  • 1. Understanding Non-Completion of the Human Papillomavirus Vaccine Series: Parent-Reported Reasons for Why Adolescents Might Not Receive Additional Doses, United States, 2012.
    Clark SJ; Cowan AE; Filipp SL; Fisher AM; Stokley S
    Public Health Rep; 2016; 131(3):390-5. PubMed ID: 27252558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parent HPV vaccine perspectives and the likelihood of HPV vaccination of adolescent males.
    Clark SJ; Cowan AE; Filipp SL; Fisher AM; Stokley S
    Hum Vaccin Immunother; 2016; 12(1):47-51. PubMed ID: 26225463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human Papillomavirus Vaccine: Continuation, Completion, and Missed Opportunities.
    Richards MJ; Peters M; Sheeder J
    J Pediatr Adolesc Gynecol; 2016 Apr; 29(2):117-21. PubMed ID: 26300233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlates of human papillomavirus vaccine series completion among young adult female initiators.
    Rahman M; Laz TH; McGrath C; Berenson AB
    Hum Vaccin Immunother; 2014; 10(8):2163-7. PubMed ID: 25424919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age at HPV vaccine initiation and completion among US adolescent girls: trend from 2008 to 2012.
    Rahman M; McGrath CJ; Hirth JM; Berenson AB
    Vaccine; 2015 Jan; 33(5):585-7. PubMed ID: 25529289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with parental reasons for "no-intent" to vaccinate female adolescents with human papillomavirus vaccine: National Immunization Survey - Teen 2008-2012.
    Cheruvu VK; Bhatta MP; Drinkard LN
    BMC Pediatr; 2017 Feb; 17(1):52. PubMed ID: 28193249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Comparison of Parent- and Provider-Reported Human Papillomavirus Vaccination of Adolescents.
    Adjei Boakye E; Tobo BB; Osazuwa-Peters N; Mohammed KA; Geneus CJ; Schootman M
    Am J Prev Med; 2017 Jun; 52(6):742-752. PubMed ID: 27890518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized intervention of reminder letter for human papillomavirus vaccine series completion.
    Chao C; Preciado M; Slezak J; Xu L
    J Adolesc Health; 2015 Jan; 56(1):85-90. PubMed ID: 25438965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human Papillomavirus Infection and Vaccination.
    Valentino K; Poronsky CB
    J Pediatr Nurs; 2016; 31(2):e155-66. PubMed ID: 26586310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with parental intentions for male human papillomavirus vaccination: results of a national survey.
    Dempsey AF; Butchart A; Singer D; Clark S; Davis M
    Sex Transm Dis; 2011 Aug; 38(8):769-76. PubMed ID: 21336230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlates of Human Papillomavirus Vaccine Completion Among Adolescent Girl Initiators.
    Rahman M; Laz TH; McGrath CJ; Berenson AB
    Clin Pediatr (Phila); 2015 Dec; 54(14):1328-33. PubMed ID: 25848128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human papillomavirus vaccine uptake among males 11-26 years in United States: findings from the National Health and Nutrition Examination Survey, 2011-2012.
    Pierre-Victor D; Mukherjee S; Bahelah R; Madhivanan P
    Vaccine; 2014 Nov; 32(49):6655-8. PubMed ID: 25446825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in Human Papillomavirus Vaccine Safety Concerns and Adverse Event Reporting in the United States.
    Sonawane K; Lin YY; Damgacioglu H; Zhu Y; Fernandez ME; Montealegre JR; Cazaban CG; Li R; Lairson DR; Lin Y; Giuliano AR; Deshmukh AA
    JAMA Netw Open; 2021 Sep; 4(9):e2124502. PubMed ID: 34533574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and predictors of human papillomavirus vaccination in adolescent girls.
    Palli SR; Mehta S; Aparasu RR
    J Am Pharm Assoc (2003); 2012; 52(1):52-8. PubMed ID: 22257616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the decision-making process in the family on HPV vaccination rates among adolescents 9-17 years of age.
    Berenson AB; Laz TH; Hirth JM; McGrath CJ; Rahman M
    Hum Vaccin Immunother; 2014; 10(7):1807-11. PubMed ID: 25424786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parental beliefs and knowledge about male human papillomavirus vaccination in the US: a survey of a pediatric clinic population.
    Griebeler M; Feferman H; Gupta V; Patel D
    Int J Adolesc Med Health; 2012; 24(4):315-20. PubMed ID: 23183731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A qualitative study investigating knowledge and attitudes regarding human papillomavirus (HPV) and the HPV vaccine among parents of immunosuppressed children.
    Seale H; Trung L; Mackie FE; Kennedy SE; Boros C; Marshall H; Tidswell J; Shaw PJ; Montgomery K; MacIntyre CR
    Vaccine; 2012 Nov; 30(49):7027-31. PubMed ID: 23059356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The HPV vaccine: are dosing recommendations being followed?
    Tan W; Viera AJ; Rowe-West B; Grimshaw A; Quinn B; Walter EB
    Vaccine; 2011 Mar; 29(14):2548-54. PubMed ID: 21300098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acceptability of the human papillomavirus vaccine and reasons for non-vaccination among parents of adolescent sons.
    Donahue KL; Stupiansky NW; Alexander AB; Zimet GD
    Vaccine; 2014 Jun; 32(31):3883-5. PubMed ID: 24844150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors associated with human papillomavirus vaccine-series initiation and healthcare provider recommendation in US adolescent females: 2007 National Survey of Children's Health.
    Lau M; Lin H; Flores G
    Vaccine; 2012 Apr; 30(20):3112-8. PubMed ID: 22425179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.